CFA
CELG

Carroll Financial Associates’s Celgene Corp CELG Stock Holding History

Carroll Financial Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-313
Closed -$31K – 1798
2019
Q3 		$31K Hold
313
– – ﹤0.01% 720
2019
Q2 		$28K Hold
313
– – ﹤0.01% 742
2019
Q1 		$29K Sell
313
-30
-9% -$2.62K ﹤0.01% 669
2018
Q4 		$30K Sell
343
-157
-31% -$11.6K ﹤0.01% 579
2018
Q3 		$44K Sell
500
-400
-44% -$35.3K ﹤0.01% 536
2018
Q2 		$71K Sell
900
-510
-36% -$42.3K 0.01% 446
2018
Q1 		$125K Buy
1,410
+23
+2% +$2.21K 0.01% 341
2017
Q4 		$144K Sell
1,387
-161
-10% -$18.2K 0.02% 314
2017
Q3 		$216K Buy
1,548
+584
+61% +$79.5K 0.02% 255
2017
Q2 		$125K Hold
964
– – 0.02% 335
2017
Q1 		$119K Buy
964
+400
+71% +$47.9K 0.02% 329
2016
Q4 		$65K Hold
564
– – 0.01% 419
2016
Q3 		$58K Hold
564
– – 0.01% 438
2016
Q2 		$55K Sell
564
-16
-3% -$1.66K 0.01% 428
2016
Q1 		$58K Buy
580
+16
+3% +$1.65K 0.01% 404
2015
Q4 		$67K Buy
564
+60
+12% +$6.94K 0.01% 355
2015
Q3 		$58K Sell
504
-28
-5% -$3.48K 0.01% 367
2015
Q2 		$62K Buy
532
+140
+36% +$16K 0.01% 337
2015
Q1 		$45K Buy
392
+106
+37% +$12.7K 0.02% 303
2014
Q4 		$33K Sell
286
-354
-55% -$37.3K 0.02% 295
2014
Q3 		$69K Buy
640
+376
+142% +$33.9K 0.02% 263
2014
Q2 		$23K Sell
264
-102
-28% -$7.76K 0.01% 456
2014
Q1 		$26K Buy
366
+140
+62% +$11.1K 0.01% 383
2013
Q4 		$19K Hold
226
– – 0.01% 431
2013
Q3 		$17K Buy
+226
New +$15.8K 0.01% 450

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Carroll Financial Associates's CELG Position: Q4 2019 in Review

Carroll Financial Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 313 shares — an estimated $31K sold.

Carroll Financial Associates first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $216K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Carroll Financial Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Carroll Financial Associates sold 313 Celgene Corp shares in Q4 2019, an estimated $31K.
  • Carroll Financial Associates first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
  • Carroll Financial Associates's Celgene Corp position peaked at $216K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Carroll Financial Associates's 13F filing for Q4 2019, filed 8 Jan 2020.